Prostate cancer treatment costs increase more rapidly than for any other cancer—how to reverse the trend?

According to GLOBOCAN, about 1.41 million new prostate cancer (PCa) cases were registered in the year 2020 globally. The corresponding socio-economic burden is enormous. Anti-cancer mRNA-based therapy is a promising approach, the principle of which is currently applied for anti-COVID-19 vaccination,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellinger, J., Alajati, A., Kubatka, P., Giordano, F. A., Ritter, M., Costigliola, V., Golubnitschaja, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886338/
https://www.ncbi.nlm.nih.gov/pubmed/35251382
http://dx.doi.org/10.1007/s13167-022-00276-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886338/
https://www.ncbi.nlm.nih.gov/pubmed/35251382
http://dx.doi.org/10.1007/s13167-022-00276-3

Ejemplares similares